RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.3B
AUM Growth
+$879M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
63
New
Increased
Reduced
Closed

Top Buys

1
+$381M
2
+$264M
3
+$71.9M
4
NAMS icon
NewAmsterdam Pharma
NAMS
+$59.5M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$55.5M

Top Sells

1
+$368M
2
+$91M
3
+$62.4M
4
HLVX
HilleVax
HLVX
+$29.1M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$26.7M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$62.3M 1.18%
4,810,508
27
$59.2M 1.12%
5,963,565
28
$58.5M 1.1%
4,417,259
29
$55.5M 1.05%
+3,069,531
30
$54.2M 1.02%
3,178,476
31
$48.2M 0.91%
4,691,178
+3,063
32
$47.8M 0.9%
2,007,946
33
$47M 0.89%
9,770,773
34
$45.6M 0.86%
4,398,453
35
$44M 0.83%
2,329,958
-19,524,000
36
$43.3M 0.82%
2,122,465
37
$38.3M 0.72%
11,609,704
38
$36.8M 0.7%
13,150,849
39
$35.6M 0.67%
6,067,483
40
$32.1M 0.61%
3,773,517
41
$31.9M 0.6%
1,762,000
42
$29.3M 0.55%
3,370,506
43
$20.2M 0.38%
3,009,678
44
$18.7M 0.35%
6,144,881
45
$18.7M 0.35%
2,971,231
46
$18M 0.34%
3,426,286
47
$17.8M 0.34%
3,525,754
+935,850
48
$17.1M 0.32%
7,805,129
49
$15.4M 0.29%
1,400,001
50
$8.65M 0.16%
+937,500
1
2
3